数量	产品目录编号	订购说明	数量 / 包装	公开价
			96-Well Plate

数量	产品目录编号	订购说明	数量 / 包装	公开价
	48-602MAG	Buffer Detection Kit for Magnetic Beads	1 Kit

344095 Sigma-AldrichFluvastatin, Sodium Salt - CAS 93957-55-2 - Calbiochem

A synthetic HMG-CoA reductase inhibitor (IC₅₀ = 40-100 nM for human liver microsomes) that acts as an anti-hypercholesterolemic agent.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

MSDS
分析证书
参考
Data Sheet

同义词: (±)-(3Rʹ,5Sʹ,6E)-7-[3-(4-Fluorophenyl)-1-isopropylindol-2-yl]-3,5-dihydroxy-6-heptenoate, sodium

Primary Target: HMG-CoA reductase

View Products on Sigmaaldrich.com

Recommended Products

概述

Replacement Information

重要规格表

CAS #	Empirical Formula
93957-55-2	C₂₄H₂₅FNNaO₄

价格及供货情况

产品目录编号	库存情况	包装	数量 / 包装	价格	数量
344095-25MGCN	正在查询供货情况...... — 目前缺货有货停产少量现货供货情况有待确认登录查看库存有货目前缺货有货其余：另行通知其余：另行通知另行通知联系客户服务 Contact Customer Service 联系客户服务联系客户服务	塑胶安瓿;塑胶针药瓶	25 mg	正在检索价格...... 无法检索价格。最小订购数量为倍数 Maximum Quantity is 以订单确认为准更多信息您节约了 ()。 — Request Pricing 登录查看价格	查看库存情况 —	添加到收藏夹添加到收藏夹添加到我的收藏夹

Description
Overview	A synthetic HMG-CoA reductase inhibitor (IC₅₀ = 40-100 nM for human liver microsomes) that acts as an anti-hypercholesterolemic agent. Decreases the basal MMP-1 levels in culture media of endothelial cells in a time- and dose-dependent manner. Inhibits the formation of TBA-reactive substances in Fe(II)-supported peroxidation of liposomes (IC₅₀ = 12 µM). Also available as a 10 mM solution in H₂O(Cat. No. 344096).
Catalogue Number	344095
Brand Family	Calbiochem®
Synonyms	(±)-(3Rʹ,5Sʹ,6E)-7-[3-(4-Fluorophenyl)-1-isopropylindol-2-yl]-3,5-dihydroxy-6-heptenoate, sodium

References
References	Yamamoto, A., et al. 2001. J. Pharm. Pharmacol. 53, 227. Dansette, P.M., et al. 2000. Exp. Toxicol. Pathol. 52, 145. Ikeda, U., et al. 2000. Hypertension 36, 325. Levy, R.I., et al. 1993. Circulation 87 (4 Suppl.), III45. Tse, F.L.S. et al. 1992. J. Clin. Pharmacol. 32, 630. Yuan, J., et al. 1991. Atherosclerosis 87, 147.

Product Information
CAS number	93957-55-2
ATP Competitive	N
Form	Light yellow solid
Hill Formula	C₂₄H₂₅FNNaO₄
Chemical formula	C₂₄H₂₅FNNaO₄
Reversible	N
Structure formula Image
Quality Level	MQ100

Applications

Biological Information
Primary Target	HMG-CoA reductase
Primary Target IC<sub>50</sub>	40-100 nM against HMG-CoA reductase in human liver microsomes
Purity	≥98% by HPLC

Physicochemical Information
Cell permeable	N

Dimensions

Materials Information

Toxicological Information

Safety Information according to GHS
RTECS	MJ9675050

Safety Information
R Phrase	R: 62-63 Possible risk of impaired fertility. Possible risk of harm to the unborn child.
S Phrase	S: 22-24/25-36/37/39-45 Do not breathe dust. Avoid contact with skin and eyes. Wear suitable protective clothing, gloves and eye/face protection. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).

Product Usage Statements

Storage and Shipping Information
Ship Code	Ambient Temperature Only
Toxicity	Carcinogenic / Teratogenic
Storage	-20°C
Protect from Light	Protect from light
Do not freeze	Ok to freeze
Special Instructions	Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.

Packaging Information
Packaged under inert gas	Packaged under inert gas

Transport Information

Supplemental Information

Specifications

Global Trade Item Number
产品目录编号	GTIN
344095-25MGCN	04055977215182

Documentation

Fluvastatin, Sodium Salt - CAS 93957-55-2 - Calbiochem MSDS

职位
物料安全数据表 (MSDS)

Fluvastatin, Sodium Salt - CAS 93957-55-2 - Calbiochem 分析证书

标题	批号
344095	输入批号

参考

参考信息概述
Yamamoto, A., et al. 2001. J. Pharm. Pharmacol. 53, 227. Dansette, P.M., et al. 2000. Exp. Toxicol. Pathol. 52, 145. Ikeda, U., et al. 2000. Hypertension 36, 325. Levy, R.I., et al. 1993. Circulation 87 (4 Suppl.), III45. Tse, F.L.S. et al. 1992. J. Clin. Pharmacol. 32, 630. Yuan, J., et al. 1991. Atherosclerosis 87, 147.

数据表

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision	10-January-2011 RFH
Synonyms	(±)-(3Rʹ,5Sʹ,6E)-7-[3-(4-Fluorophenyl)-1-isopropylindol-2-yl]-3,5-dihydroxy-6-heptenoate, sodium
Description	A synthetic, competitive inhibitor of HMG-CoA reductase that acts as anti-hypercholesterolemic agent. Unlike Lovastatin (Cat. No. 438185), Mevastatin (Cat. No. 474700), and Simvastatin (Cat. No. 567020), it does not require activation prior to use for in vitro studies. Reduces the basal MMP-1 levels in culture media of endothelial cells in a time- and dose-dependent manner. Fluvastatin is metabolized in the liver, primarily via hydroxylation of the indole ring at the 5- and 6-positions. N-Dealky-lation and b-oxidation of the side-chain also occurs. The hydroxy metabolites are also reported to have some pharmacologic activity.
Form	Light yellow solid
Intert gas (Yes/No)	Packaged under inert gas
CAS number	93957-55-2
RTECS	MJ9675050
Chemical formula	C₂₄H₂₅FNNaO₄
Structure formula
Purity	≥98% by HPLC
Solubility	H₂O (30 mg/ml), DMSO, or Methanol
Storage	Protect from light -20°C
Do Not Freeze	Ok to freeze
Special Instructions	Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Toxicity	Carcinogenic / Teratogenic
Merck USA index	14, 4218
References	Yamamoto, A., et al. 2001. J. Pharm. Pharmacol. 53, 227. Dansette, P.M., et al. 2000. Exp. Toxicol. Pathol. 52, 145. Ikeda, U., et al. 2000. Hypertension 36, 325. Levy, R.I., et al. 1993. Circulation 87 (4 Suppl.), III45. Tse, F.L.S. et al. 1992. J. Clin. Pharmacol. 32, 630. Yuan, J., et al. 1991. Atherosclerosis 87, 147.

种类

Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Lipid Signaling Inhibitors > HMG-CoA (3-Hydroxy-3-Methylglutaryl Coenzyme A) Reductase Inhibitors

此产品已添加到您的购物车。